Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Sale of 500 INBX shares, $55.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Inhibrx Biosciences, Inc. (INBX) | Sale | 500 | $55.9K |
| Sep 10, 2026 | Inhibrx Biosciences, Inc. (INBX) | Sale | 500 | $57.6K |
| Jun 4, 2026 | Inhibrx Biosciences, Inc. (INBX) | Grant/Award | 15,000 | n/a |
| May 29, 2025 | Inhibrx Biosciences, Inc. (INBX) | Grant/Award | 15,000 | n/a |
| Aug 30, 2024 | Inhibrx Biosciences, Inc. (INBX) | Purchase | 10,000 | $139.8K |
| May 30, 2024 | Inhibrx Biosciences, Inc. (INXB) | Grant/Award | 30,000 | n/a |
| May 30, 2024 | Inhibrx, Inc. (INBX) | Disposition to Issuer | 3,500 | n/a |
| Apr 17, 2023 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Exercise/Conversion | 1,250 | n/a |
| Jan 20, 2023 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/Award | 149,365 | n/a |
| Jan 17, 2023 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Other (see footnotes) | 1,655 | $5.4K |